Ultra Violette recalled 44,497 tubes of its Mini SPF Mates kit on August 22, 2025. The sunscreen products showed inconsistent SPF results, including readings as low as SPF 4. Consumers must stop use immediately and contact the distributor for guidance.
Subpotent/Super-potent Product: Testing of the SPF 50 sunscreen revealed inconsistency in SPF results ranging from SPF 4, 10, 21, 26, 33, 60, 61, and 64.
Consumers and healthcare providers should stop using this product immediately. Contact GRACE & FIRE PTY LTD or your healthcare provider for guidance. Notification method: Letter
The recalled product is the Ultra Violette Mini SPF Mates kit, which includes Velvet Screen SPF 50 and Supreme Sunscreen SPF 50. The products were distributed by Grace & Fire USA Inc. The lot numbers affected are A2453 and A2454, with expiration dates of November 30, 2026, and December 31, 2026.
Testing revealed the SPF 50 sunscreen's effectiveness varied greatly, with some tests showing SPF levels as low as 4. This inconsistency poses a significant risk to consumers relying on these products for sun protection.
There are no reported injuries or incidents associated with the recalled products at this time. However, the potential for inadequate sun protection is a serious concern.
Consumers should stop using the affected products immediately. For further guidance, contact GRACE & FIRE PTY LTD or consult your healthcare provider.
For more information, visit the FDA website at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0641-2025. Consumers can also reach out to the distributor for assistance.
Get notified about recalls in categories you care about.
Bristol-Myers Squibb recalled 12,778 vials of Opdualag injection on October 21, 2025. The recall stems from a lack of assurance of sterility. The affected products were distributed nationwide in the United States.
Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, on October 10, 2025, due to failed impurities specifications. The recall affects several lot numbers distributed nationwide. Consumers must stop using the affected capsules immediately.
Lannett Company, Inc. recalled 46,848 bottles of Niacin Extended-release Tablets on October 10, 2025. The recall follows reports of failed dissolution specifications, which could affect medication effectiveness. Consumers should stop using the product immediately and consult healthcare providers for guidance.